Targeting Aberrant TGF-β Signaling in Pre-Clinical Models of Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
7
Page:
504-514
Author(s):
Anna Alexeyevna Mourskaia, Jason Jonathan Northey and Peter Michael Siegel
PARP Inhibitor Development for Systemic Cancer Targeting
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
7
Page:
515-523
Author(s):
Tomasz Zaremba and Nicola Jane Curtin
Tumor Targeting with RGD Peptide Ligands-Design of New Molecular Conjugates for Imaging and Therapy of Cancers
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
7
Page:
552-558
Author(s):
Elisabeth Garanger, Didier Boturyn and Pascal Dumy
Applications of Artificial Neural Networks in Medical Science
Journal:
Current Clinical Pharmacology
Volume:
2
Page:
217-226
Author(s):
Jigneshkumar L. Patel and Ramesh K. Goyal
Human-Based In Vitro Experimental Systems for the Evaluation of Human Drug Safety
Journal:
Current Drug Safety
Volume:
2
Page:
193-199
Author(s):
Albert P. Li
Oleamide Derivatives are Prototypical Anti-Metastasis Drugs that Act by Inhibiting Connexin 26
Journal:
Current Drug Safety
Volume:
2
Page:
204-211
Author(s):
Hiroshi Nojima, Yusuke Ohba and Yasuyuki Kita
Structure-Function Relationships of Plasminogen Activator Inhibitor-1 and Its Potential as a Therapeutic Agent
Journal:
Current Drug Targets
Volume:
8
Page:
971-981
Author(s):
Jacqueline M. Cale and Daniel A. Lawrence
PAI-1 - A Potential Therapeutic Target in Cancer
Journal:
Current Drug Targets
Volume:
8
Page:
1030-1041
Author(s):
Peter A. Andreasen
Hypertension, Anti-Hypertensive Therapy and Neoplasia
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2539-2544
Author(s):
Patrick K.Y. Goon, Paul S. Stonelake and Gregory Y.H. Lip
Insights into the Platelet Releasate
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
2640-2646
Author(s):
J. A. Coppinger and P. B. Maguire